CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CerISMA focuses on validating a molecular imaging camera, LightPath™, which uses Cerenkov Luminescence Imaging to assist surgeons in accurately identifying and removing cancerous tissues during operations. This technology aims to reduce re-operations and associated healthcare costs.
Cancer is not only a leading public health challenge in Europe, it is also a growing economic challenge.
Over three million cases are currently diagnosed each year across the continent.
Forecasts show that by 2020 almost half of the population will be diagnosed with the disease in their lifetime.
The cost of cancer for the EU is €126 billion per year and rising.
The health and economic implications of cancer therefore provide a compelling business opportunity for technologies that can improve he…
LIGHTPOINT MEDICAL LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
